A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamsters

导出原文传递学术成果认领

作者单位 NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Beijing 100050, China ^[1] Department of Internal Medicine and Liver Center, School of Medicine, Yale University, New Haven, CT 06520, USA ^[2] Department of Internal Medicine and Liver Center, School of Medicine, Yale University, New Haven, CT 06520, USA;Personalized Drug Therapy Key Laboratory of Sichuan Province, Hospital of the University of Electronic Science and Technology of China and Sichuan Provincial People's Hospital, Chengdu 610072, China ^[3] NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Beijing 100050, China;Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, China ^[4]

关键词 ASBT inhibitor NAFLD CYP7A1 AMPKα PPARα

栏目名称 Hepatic and Pulmonary Pharmacology

发布时间 2019-08-06

基金项目

This study was supported by the National Nature Scientific Foundation of China the CAMS Initiative for Innovation Fund for Medical Sciences (CIFMS) the Beijing Nature Scientific Foundation (7162130).We thank the Liver Meeting 2017 held by the American Association for the Study of Liver Diseases for receiving and publishing this document as a meeting abstract

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0
被引3
下载0

中国药理学报（英文版）

2019年40卷7期

895-907页

SCIMEDLINEISTICCSCDCABP

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamsters

中国药理学报（英文版）

相似文献

中国药理学报（英文版）

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamsters

中国药理学报（英文版）

相似文献

中国药理学报（英文版）

相关期刊

检索历史清除